DE69029197T2 - Gamma-retinoinsäure-rezeptor - Google Patents

Gamma-retinoinsäure-rezeptor

Info

Publication number
DE69029197T2
DE69029197T2 DE69029197T DE69029197T DE69029197T2 DE 69029197 T2 DE69029197 T2 DE 69029197T2 DE 69029197 T DE69029197 T DE 69029197T DE 69029197 T DE69029197 T DE 69029197T DE 69029197 T2 DE69029197 T2 DE 69029197T2
Authority
DE
Germany
Prior art keywords
retinoic acid
acid receptor
gamma retinoic
receptor
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69029197T
Other languages
English (en)
Other versions
DE69029197D1 (de
Inventor
Fumimaro Takaku
Michio Imawari
Takashi Ishikawa
Ronald Mark Evans
Kazuhiko Umesono
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sloan Kettering Institute for Cancer Research
Salk Institute for Biological Studies
Original Assignee
Sloan Kettering Institute for Cancer Research
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research, Salk Institute for Biological Studies filed Critical Sloan Kettering Institute for Cancer Research
Publication of DE69029197D1 publication Critical patent/DE69029197D1/de
Application granted granted Critical
Publication of DE69029197T2 publication Critical patent/DE69029197T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/846—Liver
DE69029197T 1989-06-22 1990-06-22 Gamma-retinoinsäure-rezeptor Expired - Fee Related DE69029197T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/370,407 US5260432A (en) 1989-06-22 1989-06-22 Human gamma retinoic acid receptor DNA
PCT/US1990/003564 WO1990015815A1 (en) 1989-06-22 1990-06-22 Gamma retinoic acid receptor

Publications (2)

Publication Number Publication Date
DE69029197D1 DE69029197D1 (de) 1997-01-02
DE69029197T2 true DE69029197T2 (de) 1997-04-10

Family

ID=23459521

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69029197T Expired - Fee Related DE69029197T2 (de) 1989-06-22 1990-06-22 Gamma-retinoinsäure-rezeptor

Country Status (10)

Country Link
US (4) US5260432A (de)
EP (1) EP0479916B1 (de)
JP (1) JP3240056B2 (de)
KR (1) KR0159106B1 (de)
AT (1) ATE145406T1 (de)
AU (1) AU640940B2 (de)
CA (1) CA2066692A1 (de)
DE (1) DE69029197T2 (de)
ES (1) ES2094157T3 (de)
WO (1) WO1990015815A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571692A (en) * 1987-12-02 1996-11-05 The Salk Institute For Biological Studies Retinoic acid receptor α, vectors and cells comprising the same DNA encoding
US5260432A (en) * 1989-06-22 1993-11-09 Sloan-Kettering Institute For Cancer Research Human gamma retinoic acid receptor DNA
EP0683227A1 (de) * 1989-06-30 1995-11-22 Institut National De La Sante Et De La Recherche Medicale (Inserm) Menschlicher Retinoinsäure-Rezeptor und dafür kodierende Gene
EP0999271A3 (de) * 1990-02-09 2003-04-02 The Salk Institute For Biological Studies Retinoid-rezeptor-Zusammensetzungen und Verfahren
US5641652A (en) * 1990-03-22 1997-06-24 The Salk Institute For Biological Studies Insect retinoid-like receptor compositions and methods
US5861274A (en) * 1990-03-22 1999-01-19 The Salk Institute For Biological Studies Nucleic acids encoding peroxisome proliferator-activated receptor
US5922596A (en) * 1990-12-10 1999-07-13 Bristol-Myers Squibb Co. Promoter of the retinoic acid receptor gene for directing gene expression
US5756448A (en) * 1992-02-26 1998-05-26 The General Hospital Corporation Constitute activator of retinoid (CAR) receptor polypeptides
US6989242B1 (en) 1992-02-26 2006-01-24 The General Hospital Coporation Car receptors and related molecules and methods
CA2155728C (en) * 1993-02-12 2000-04-25 Gerald R. Crabtree Regulated transcription of targeted genes and other biological events
US6891021B2 (en) 1993-02-12 2005-05-10 Board Of Trustees Of The Leland Stanford Junior University Regulated apoptosis
CA2140354A1 (en) * 1993-05-18 1994-11-24 Pierre Chambon Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
US6031149A (en) 1993-05-18 2000-02-29 Institut National De La Sante Et De La Recherche Medicale Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
WO1996000242A1 (en) * 1994-06-24 1996-01-04 Human Genome Sciences, Inc. Retinoic acid receptor epsilon
EP0769052A2 (de) * 1994-07-01 1997-04-23 The Salk Institute For Biological Studies Säugertier peroxisompoliferator-aktivierte rezeptoren und verwendungen davon
US6489441B1 (en) 1995-09-01 2002-12-03 The Salk Institute For Biological Studies Transcriptional co-repressor that interacts with nuclear hormone receptors
US5939264A (en) * 1996-07-19 1999-08-17 Iowa State University Research Foundation, Inc. Genes and genetic markers for improved reproductive traits in animals
JP2002505573A (ja) 1997-04-24 2002-02-19 アンスティテュ ナショナル デュ ラ サンテ エ デュ ラ ルシェルシュ メディカル マトリックスメタロプロテイナーゼ遺伝子の発現を調節することにおける使用のための方法および組成物
AUPP012097A0 (en) 1997-10-30 1997-11-27 Commonwealth Scientific And Industrial Research Organisation Assessing lipid metabolism
US6521814B1 (en) 1997-12-22 2003-02-18 Institut National De La Santa Et De La Recherche Medicale Use of ligands for treatment of diseases responsive to retinoids
US6665594B1 (en) * 2001-12-13 2003-12-16 The United States Of America As Represented By The Secretary Of The Navy Plug and play modular mission payloads
EP1487965A4 (de) 2002-02-25 2006-11-15 Mpex Pharmaceuticals Inc Minizellzusammensetzungen und -verfahren
US8309687B2 (en) * 2007-03-15 2012-11-13 Reverse Proteomics Research Institute Co., Ltd. Biomarker specific for cancer
US10119150B2 (en) 2012-05-13 2018-11-06 Allele Biotechnology & Pharmaceuticals, Inc. Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA
US10155929B2 (en) 2012-05-13 2018-12-18 Allele Biotechnology & Pharmaceuticals, Inc. Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
DK2850179T3 (da) * 2012-05-13 2019-06-17 Allele Biotechnology & Pharmaceuticals Inc Feeder-cellefri afledning af human-inducerede pluripotente stamceller med syntetisk messenger-rna

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171671A (en) * 1987-12-02 1992-12-15 The Salk Institute For Biological Studies Retinoic acid receptor composition
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
ATE143413T1 (de) * 1987-12-16 1996-10-15 Pasteur Institut Retinoesäurerezeptor und derivate davon, beide substanzen codierende dns und die verwendung der proteine und der dns
US5260432A (en) * 1989-06-22 1993-11-09 Sloan-Kettering Institute For Cancer Research Human gamma retinoic acid receptor DNA
US5091518A (en) * 1989-11-16 1992-02-25 The Salk Institute For Biological Studies Beta retinoic acid response elements compositions and assays

Also Published As

Publication number Publication date
US7033828B2 (en) 2006-04-25
CA2066692A1 (en) 1990-12-23
AU6051990A (en) 1991-01-08
EP0479916B1 (de) 1996-11-20
WO1990015815A1 (en) 1990-12-27
AU640940B2 (en) 1993-09-09
US20040171800A9 (en) 2004-09-02
ATE145406T1 (de) 1996-12-15
DE69029197D1 (de) 1997-01-02
US5530094A (en) 1996-06-25
JPH05501349A (ja) 1993-03-18
KR0159106B1 (ko) 1998-11-16
US6284870B1 (en) 2001-09-04
US5260432A (en) 1993-11-09
EP0479916A1 (de) 1992-04-15
ES2094157T3 (es) 1997-01-16
EP0479916A4 (en) 1992-10-07
JP3240056B2 (ja) 2001-12-17
US20020077457A1 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
DE69029197D1 (de) Gamma-retinoinsäure-rezeptor
FI861882A (fi) Underlag foer odling utan mull.
AU630950B2 (en) Fibronectin binding protein as well as its preparation
DE410402T1 (de) Ein automatisches system zum anpassen der ausgangsimpedanz von schnellen cmos-treibern.
DE69022540T2 (de) Verfahren zur 1,2 Dehydrogenierung der Azasteroiden.
NO902629L (no) Hellingskompensator for hurtigkjoerende kjoeretoey, saerlig skinnekjoeretoey.
DE3577848D1 (de) -6-substituierte-4-dialkylaminotetrahydrobenz(c,d)indole.
IT7822513A0 (it) Endoprotesi con un collegamento metallo-ceramica, nonche'procedimento per la sua realizzazione.
NO881537L (no) Fremgangsmaate for fremstilling av 6-substituert-2',3'-dideoksynukleosider.
FI882562A0 (fi) Fibronektinbindande protein och foerfarande foer dess framstaellning.
DK0817851T5 (da) DNA, der koder for humant papillomvirus type 18
FI880588A0 (fi) Interpolymerkompositioner och membraner av eten-akrylsyratyp, vilka har foerbaettrad glidbarhet och foerminskad faestfoermaoga.
DE69015492T2 (de) Unter Hochspannung arbeitendes, isolierendes Vakuumgefäss.
ES2023490B3 (es) Proceso de coquizacion premium.
DE69113750D1 (de) Dimerisierungsverfahren für n-Buten.
DE69010597D1 (de) Tropferspitze für Flüssigkeiten.
EP0112299A3 (de) Verfahren zur Reinigung von Superoxid-Dismutase mittels Affinitätschromatographie
FR2477874B1 (fr) Composition de parfum a base de tricyclo (5.2.1.0.2,6) decane-2-carboxylate de methyle et son procede de preparation
ES8400401A1 (es) "un procedimiento para preparar un 1,4-dialcohilo inferior-3-alcoxicarbonilo inferior-pirrol-2-acetato de alcohilo inferior".
MX9604079A (es) Ensayo homogeneo de sondas genicas con un receptor dirigido contra el marcador.
EP0342422A3 (de) Verfahren zur Herstellung von 2',3'-Dideoxynucleosiden und dabei verwendete neue Zwischenprodukte
NO883215D0 (no) Vekstfremmende middel.
IT8723036A0 (it) Procedimento per la raffinazione del carbone mediante agglomerazione selettiva.
ATE95241T1 (de) Durch sterole regulierbare promoterelemente.
FR2632637B1 (fr) Ethers de la 2-amino-7-hydroxytetraline

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee